Transcatheter closure of congenital ventricular septal defects using the Amplatzer Duct Occluder II device: preliminary data from a Tunisian monocentric study.

Autor:	Slim M, Ben Farhat S, Ben Ouannes S, Chrigui R, Yahia F, Thabet H, Ghardallou H, Gribaa R, ElHraiech A, Neffati E
Jazyk:	angličtina
Zdroj:	La Tunisie medicale [Tunis Med] 2022 juin; Vol. 100 (6), pp. 450-454.
Abstrakt:	Introduction: Percutaneous closure of congenital ventricular septal defects (VSDs) represents a promising alternative to surgery with lower rate of complications and shorter hospital stay. Its main limitation is the choice of the appropriate device for each type of defect. Aim: To report the experience of the service of cardiology (Sahloul hospital, Sousse, Tunisia) in percutaneous closure of congenital VSDs with Amplatzer Duct Occluder II (ADOII). Methods: This was a retrospective, monocentric study, conducted from January 2013 to December 2017. The study included patients treated by percutaneous closure of congenital VSDs with the ADOII device. Results: Twelve patients (6 boys; 6 girls) were included. The mean±SD of patients' age and weight were 65±41 months and 23±10 kg, respectively. VSDs were peri-membranous (n=9) and muscular (n=3), and defects were restrictive (n=11) and non-restrictive (n=1). The mean (minimum-maximum) size of VSDs was 4.72 (3-6) mm. Eleven ADOII prostheses were successfully implanted. One failure procedure was noted with migration of the device into the pulmonary artery. A second child with perimembranous defect developed transient atrioventricular block. No deaths occurred. Conclusion: The present early experience shows that percutaneous closure with ADOII device of perimembranous and trabecular VSDs is safe and effective.
Databáze:	MEDLINE
Externí odkaz:	Zobrazit plný text záznamu